
|Articles|January 16, 2006
Once-daily treatment for psoriasis approved
Advertisement
The FDA has approved Taclonex, a combination topical consisting of calcipotriene 0.005% and betamethasone dipropionate 0.064%, for the treatment of psoriasis vulgaris in adults. Warner Chilcott plans to launch the new ointment in the first half of 2006.
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Congressional Spending Bill to Include Key PBM Contracting Reform
2
Scripted for Her: Transforming Care for Older Women
3
Pharma, OTC Supplement Are Markets Expected to Grow Billions Come 2032
4
Q&A: New Medicare Drug Prices Proving Detrimental to Pharmacy Cashflow
5









































































































































































































